{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:39:44Z","timestamp":1782401984865,"version":"3.54.5"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamadermatol.2018.3715","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:34:55Z","timestamp":1543253695000},"page":"90","source":"Crossref","is-referenced-by-count":31,"title":["Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria"],"prefix":"10.1001","volume":"155","author":[{"given":"Sydney E.","family":"Liang","sequence":"first","affiliation":[{"name":"currently a medical student at New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Peterson","sequence":"additional","affiliation":[{"name":"currently a medical student at New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Soter","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"dbr180024r1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/all.2011.66.issue-3","article-title":"Unmet clinical needs in chronic spontaneous urticaria: a GA2LEN task force report.","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"issue":"7","key":"dbr180024r2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria: the 2017 revision and update.","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"dbr180024r3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2500\/aap.2018.39.4121","article-title":"Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.","volume":"39","author":"Kaplan","year":"2018","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"dbr180024r4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/0019-5154.156325","article-title":"Treatment of refractory chronic urticaria.","volume":"60","author":"Mehta","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"3","key":"dbr180024r5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update.","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"dbr180024r6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1468-3083.2007.02510.x","article-title":"Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs antihistamine in patients with chronic idiopathic urticaria.","volume":"22","author":"Engin","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"dbr180024r7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jaip.2014.06.004","article-title":"Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.","volume":"2","author":"Morgan","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"dbr180024r8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/jlb.1997.62.issue-6","article-title":"Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction.","volume":"62","author":"Debol","year":"1997","journal-title":"J Leukoc Biol"},{"issue":"3","key":"dbr180024r9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0006-2952(92)90449-S","article-title":"Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone.","volume":"44","author":"Bozeman","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"dbr180024r10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1034\/j.1398-9995.1999.00187.x","article-title":"Urticaria treated with dapsone.","volume":"54","author":"Boehm","year":"1999","journal-title":"Allergy"},{"issue":"3","key":"dbr180024r11","first-page":"254","article-title":"Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study.","volume":"85","author":"Cassano","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"dbr180024r12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jde.2012.39.issue-5","article-title":"Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment.","volume":"39","author":"Noda","year":"2012","journal-title":"J Dermatol"},{"issue":"2","key":"dbr180024r13","first-page":"171","article-title":"Effect of dapsone on haemoglobin concentration in patients with leprosy.","volume":"62","author":"Byrd","year":"1991","journal-title":"Lepr Rev"},{"issue":"6","key":"dbr180024r14","first-page":"776","article-title":"Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin.","volume":"11","author":"Grindulis","year":"1984","journal-title":"J Rheumatol"},{"issue":"1","key":"dbr180024r15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jaip.2016.08.010","article-title":"The comparative safety of multiple alternative agents in refractory chronic urticaria patients.","volume":"5","author":"Seth","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"dbr180024r16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/09537100802315110","article-title":"Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.","volume":"19","author":"Vancine-Califani","year":"2008","journal-title":"Platelets"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2715087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T15:30:17Z","timestamp":1547047817000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.3715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.3715","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}